TAG
Innate Repair Receptor Agonist in Phase 2 Development
13 Apr 2026
Endogenous Neuropeptide With Limited Clinical Evidence for CIRS
13 Apr 2026
Approved in 35+ Countries (Except US, EU, UK, Australia, Canada)
13 Apr 2026
Russian-Approved Neuroprotective Peptide (ACTH Analog)
13 Apr 2026
Russian-Approved Anxiolytic Peptide (Tuftsin Analog)
13 Apr 2026
Investigational Mitochondrial Protective Peptide in Active Development
13 Apr 2026
Human Cathelicidin Antimicrobial Peptide (Preclinical Only)
13 Apr 2026
Investigational Reproductive Peptide in Active Research
13 Apr 2026
Tripeptide Fragment With Zero Human Evidence
13 Apr 2026
Angiotensin IV Analog With No Human Safety Data
13 Apr 2026
Failed Drug Candidate With Misleading GRAS Status
13 Apr 2026
Glucagon-Like Peptide-1 Agonists for Metabolic Optimization and Weight Management
13 Apr 2026
Bug report, content request, or general comment — we read everything.